Literature DB >> 2064223

The discovery and biologic properties of cephalosporin-based inhibitors of PMN elastase.

P Davies1, B M Ashe, R J Bonney, C Dorn, P Finke, D Fletcher, W A Hanlon, J L Humes, A Maycock, R A Mumford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2064223     DOI： 10.1111/j.1749-6632.1991.tb17021.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Elastase inhibitors as potential therapies for ELANE-associated neutropenia.

Authors:  Vahagn Makaryan; Merideth L Kelley; Breanna Fletcher; Audrey Anna Bolyard; A Andrew Aprikyan; David C Dale
Journal:  J Leukoc Biol       Date:  2017-07-28       Impact factor: 4.962

2.  Detection of extracellular neutrophil elastase in hamster lungs after intratracheal instillation of E. coli lipopolysaccharide using a fluorogenic, elastase-specific, synthetic substrate.

Authors:  A Rudolphus; J Stolk; C van Twisk; C J van Noorden; J H Dijkman; J A Kramps
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation.

Authors:  C G Llewellyn-Jones; D A Lomas; R A Stockley
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

4.  Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase.

Authors:  J B Doherty; S K Shah; P E Finke; C P Dorn; W K Hagmann; J J Hale; A L Kissinger; K R Thompson; K Brause; G O Chandler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.